Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells
Cleopatrabobb
19 min
Knowledge
Description
<p>Vor Biopharma's CEO Dr. Robert Ang explains the company's lead engineered hematopoietic cell (eHSC) product candidate, genome engineering of HSCs, and the cell manufacturing process needed to leverage genome engineering technologies for the cells they're creating.</p>
Uploader
alice.wave
Episodes
1
Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells
Cleopatrabobb